Amgen: Tarlatamab Shows Survival Benefit
Amgen's Tarlatamab demonstrates superior overall survival in small cell lung cancer.
Read full article »
Amgen is a California-based multinational biopharmaceutical company that develops human therapeutics for the treatment of diseases including cancer and cardiovascular.
Read more